Arkolith/Insider Trading/DWTX/Form 4

CK Life Sciences Intl (Holdings) Inc

Director, 10% OwnerDogwood Therapeutics, Inc. (DWTX) · full profile →Form 4 · filed Mar 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2025Grant(A)284$7.01$2K284

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-024577) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML